Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
28
HHS Quote, Financials, Valuation and Earnings
Last price:
$4.52
Seasonality move
:
-1.5%
Day range:
$4.49 - $4.78
52-week range:
$4.27 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.18x
P/B ratio:
1.56x
Volume:
6.3K
Avg. volume:
17.9K
1-year change:
-38.53%
Market cap:
$33.4M
Revenue:
$185.2M
EPS (TTM):
-$4.20
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Harte-Hanks has 286.31% upside to fair value with a price target of -- per share.
HHS vs. S&P 500
-
Over the past 5 trading days, Harte-Hanks has overperformed the S&P 500 by 0.4% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Harte-Hanks does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Harte-Hanks revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Harte-Hanks reported revenues of $41.6M.
Earnings Growth
-
Harte-Hanks earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported earnings per share of -$0.05.
Enterprise value:
24.4M
EV / Invested capital:
1.14x
Price / LTM sales:
0.18x
EV / EBIT:
4.15x
EV / Revenue:
0.13x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-16.95x
Price / Operating cash flow:
167.22x
Enterprise value / EBITDA:
2.37x
Gross Profit (TTM):
$124.4M
Return On Assets:
-28.59%
Net Income Margin (TTM):
-16.83%
Return On Equity:
-145.7%
Return On Invested Capital:
-145.7%
Operating Margin:
1.92%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $204.3M | $189.8M | $181.4M | $45.4M | $41.6M | |
| Gross Profit | $140.7M | $131M | $124.4M | $31.7M | $27.5M | |
| Operating Income | $12.3M | $9.2M | $7.2M | $1.2M | $798K | |
| EBITDA | $15.4M | $12M | $10.3M | $815K | $509K | |
| Diluted EPS | $4.26 | -$0.13 | -$4.20 | -$0.02 | -$0.05 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $83.9M | $79.9M | $62.2M | $57.8M | $53.7M | |
| Total Assets | $116.9M | $111.1M | $114.9M | $113.4M | $100.6M | |
| Current Liabilities | $53.1M | $44.6M | $38.3M | $40.2M | $36.1M | |
| Total Liabilities | $161.6M | $122M | $93.9M | $93.5M | $79.2M | |
| Total Equity | -$44.7M | -$10.8M | $21M | $20M | $21.4M | |
| Total Debt | $27.1M | $5M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $31.3M | $3.1M | $1.9M | -$5.7M | -$818K | |
| Cash From Investing | -$10.7M | -$2.3M | -$3.3M | -$525K | -$103K | |
| Cash From Financing | -$15.8M | -$3.1M | -$338K | -$149K | -$68K | |
| Free Cash Flow | $26.3M | $309K | -$1.4M | -$6.2M | -$923K | |
HHS
Sector
Market Cap
$33.4M
$86.4M
Price % of 52-Week High
51.07%
66.67%
Dividend Yield
0%
0%
Shareholder Yield
0.67%
3.28%
1-Year Price Total Return
-38.54%
-14.79%
Beta (5-Year)
-0.147
0.596
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$4.61
200-day SMA
Sell
Level
$5.93
Bollinger Bands (100)
Sell
Level
4.63 - 5.27
Chaikin Money Flow
Sell
Level
-7.6M
20-day SMA
Sell
Level
$4.68
Relative Strength Index (RSI14)
Sell
Level
46.31
ADX Line
Buy
Level
14.7
Williams %R
Neutral
Level
-76.0771
50-day SMA
Sell
Level
$4.67
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Sell
Level
-18.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (13.7752)
Sell
CA Score
(Annual)
Level (-0.955)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.0254)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Stock Forecast FAQ
In the current month, HHS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HHS average analyst price target in the past 3 months is --.
-
Where Will Harte-Hanks Stock Be In 1 Year?
According to analysts, the consensus estimate is that Harte-Hanks share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Harte-Hanks?
Analysts are divided on their view about Harte-Hanks share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Harte-Hanks is a Sell and believe this share price will drop from its current level to --.
-
What Is Harte-Hanks's Price Target?
The price target for Harte-Hanks over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Harte-Hanks is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HHS?
You can purchase shares of Harte-Hanks via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Harte-Hanks shares.
-
What Is The Harte-Hanks Share Price Today?
Harte-Hanks was last trading at $4.52 per share. This represents the most recent stock quote for Harte-Hanks. Yesterday, Harte-Hanks closed at $4.53 per share.
-
How To Buy Harte-Hanks Stock Online?
In order to purchase Harte-Hanks stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
68
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for May 22
Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.
Buy
52
TRNS alert for May 22
Transcat [TRNS] is down 4.13% over the past day.
Buy
81
DY alert for May 22
Dycom Industries [DY] is up 15.76% over the past day.
